XVIVO: Early Heart support and a strong Q1 - Redeye

Redeye updates our outlook after Q1. XVIVO’s result indicated a mix of organisational improvements and strong demand. Again XVIVO beat both our and market expectations. We make a minor positive sales revision driven by a positive Abdominal revision, improved gross margins, and a slightly higher OPEX level reflecting investments in ongoing and approaching launches. We increase our base case to SEK 405 (385) with a Bull of SEK 800 and a Bear of SEK 105.

Länk till analysen i sin helhet: https://www.redeye.se/research/896895/xvivo-early-heart-support-and-a-strong-q1?utm_source=finwire&utm_medium=RSS